| Bioactivity | Revospirone (BAY Vq 7813) is a partial agonist of the 5-HT1A receptor with a Ki of 2 nmol/L. Revospirone inhibits adenylate cyclase activity with an IC50 of 124 nmol/L[1]. |
| Target | Ki: 2 nmol/L (5-HT1A).IC50: 124 nmol/L (adenylate cyclase). |
| Name | Revospirone |
| CAS | 95847-87-3 |
| Formula | C18H21N5O3S |
| Molar Mass | 387.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Löscher, W et al. The behavioural responses to 8-OH-DPAT, ipsapirone and the novel 5-HT1A receptor agonist Bay Vq 7813 in the pig. Naunyn-Schmiedeberg's archives of pharmacology vol. 342,3 (1990): 271-7. |
Revospirone
CAS: 95847-87-3 F: C18H21N5O3S W: 387.46
Revospirone (BAY Vq 7813) is a partial agonist of the 5-HT1A receptor with a Ki of 2 nmol/L. Revospirone inhibits adenyl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.